Main menu


Cell culture reagents market to reach $11.04 billion by 2029 -

REDDING, Calif., Aug. 8, 2022 (GLOBE NEWSWIRE) — According to a new market research report, Cell culture reagent market By Product (Growth Factors & Cytokines, Supplements, Cryoprotectants, Antibiotics, Buffers, Adhesins), Applications (Monoclonal Antibodies, Research, Stem Cells), End Users (Pharmaceutical & Biotech, Academic)Forecast to 2029,’ Published by Meticulus Research®the cell culture market is expected to reach $11.04 billion by 2029, at a CAGR of 12.8% during the forecast period 2022-2029.

Download a free sample report now @

Cell culture reagents serve as supplements for in vitro growth and development of cells. Reagents play a role in maintaining salt concentration, cell lysis, cell attachment, cryopreservation, and buffer capacity in cell culture. Cell culture reagents include growth factors and cytokines, cryoprotective reagents, antibiotics/antimycotics, cell dissociation reagents, buffers and chemicals, balanced salt solutions, adhering and matrix factors, and other cell culture reagents. increase.

Impact of COVID-19 Pandemic on Cell Culture Reagent Market

Understanding the dynamics and transmissibility of COVID-19 has been an important guide to prevent infection and its control strategies. Since then, researchers around the world have engaged in research related to understanding the biology of various viral variants to develop new therapeutics. These research studies have led to discoveries and new insights for developing therapeutics, vaccines, and diagnostic tools. On February 4, 2020, the Centers for Disease Control and Prevention (CDC) shipped the SARS-CoV-2 virus strain to the Biodefense and Emerging Infections Research Resources Repository (BEI Resources) for scientific and medical researchers worldwide. made available. Communities that use strains in their research.

For COVID-19-related projects, in vitro cell culture models have played an important role in research. A human lung epithelial model is currently being tested as a platform for COVID-19 research. Other models used are normal human bronchial epithelial cells, normal human small airway epithelial cells, tissue-specific extracellular matrix, and airway primary endothelial cells. The main areas of COVID-19 research have been antiviral research, vaccine development, etiology research, and viral stability research. Hence, the pandemic has had a positive impact on the growth of the cell culture reagents market.

Talk to our analysts to understand the impact of COVID-19 on your business.

The global cell culture reagents market consists of products (growth factors and cytokines, supplements, cryoprotective reagents, antibiotics/antimycotics, cell dissociation reagents, buffers and chemicals, balanced salt solutions, contamination detection kits, adhering and matrix factors, , other cell culture reagents). ), application [bioproduction (monoclonal antibody production, therapeutic protein production, vaccine production, cell and gene therapy)], diagnostics, cancer research, drug screening and development, stem cell research), end-users (pharmaceutical and biotech companies, academic and research institutions, diagnostic laboratories), and geography. The study also evaluates industry competitors and analyzes regional and country-level markets.

Based on product type, the growth factors and cytokines segment is estimated to hold the largest share of the cell culture reagents market in 2022. This segment is also expected to register the highest CAGR during the forecast period. The focus of pharmaceutical and biotech companies on serum-free media will help expand the use of external growth factors and cytokines in the coming years.

Based on application, the bioproduction segment is estimated to hold the largest share of the cell culture reagents market in 2022. This segment is also expected to register the highest CAGR during the forecast period. The major factors contributing to the growth of this segment are the increasing demand for biopharmaceutical products such as monoclonal antibodies, vaccines and therapeutic proteins, and increasing demand for cell and gene therapies.

Based on end-users, the pharmaceutical and biotech companies segment is estimated to hold the largest share of the cell culture reagents market in 2022. This segment is expected to record the highest CAGR for him during the forecast period. Factors such as increased funding, increased R&D spending by pharmaceutical and biotech companies, and expansion of production facilities are boosting the growth of this segment.

Quick purchase – Cell Culture Reagent Market Research Report:

Based on geography, North America is estimated to dominate the overall cell culture reagents market in 2022, followed by Europe and Asia Pacific. The region’s well-established healthcare system, growing adoption of advanced technologies, high prevalence of non-communicable diseases, growth in pharmaceutical research, continued capacity expansion by biopharmaceutical manufacturers and the presence of major key players , leading the North American market. However, Asia Pacific is expected to register the highest CAGR during the forecast period. Population growth is a key factor driving the healthcare and pharmaceutical sectors in the region, attracting a lot of investment from government and non-governmental organizations. Asia-Pacific countries are paving the way for many R&D activities in this field and aim to be competitive in the global biotechnology market. Moreover, increasing investments are driving the demand for cell culture products across the Asia-Pacific region.

The report also includes an extensive assessment of the product portfolios, geographic analysis, and key strategic developments adopted by key market players in the industry during the period 2019-2022. The cell culture reagent market has recently seen several organic and inorganic developments. For example, in July 2021, Sartorius AG (Germany) acquired his 51% of CellGenix GmbH (Germany) and expanded its product portfolio with additional cell culture components such as growth factors, cytokines and media. . In another example, Cytiva (US) acquired Intermountain Life Sciences (US) in June 2021, providing high-purity water, buffers and liquid cell culture media. The acquisition enabled Cytiva to strengthen its cell culture production in Utah.

Major companies operating in this market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (USA), PromoCell GmbH (Germany), Cytiva (USA), Lonza Group Ltd (Switzerland), Corning Incorporated (USA) , and Becton. , Dickinson and Company (USA), HiMedia Laboratories (India), Sartorius AG (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (USA), Miltenyi Biotec BV & Co. KG (Germany), BIOLOGOS (USA) ) ), STEMCELL Technologies Inc. (Canada), and Cell Applications, Inc. (USA).

Click here to gain more insight into the market with a detailed table of contents and figures.

Report scope:

cell culture reagent By market and product

  • reagent
    • growth factors and cytokines
    • supplement
    • Cryoprotectant reagent
    • Antibiotics/Antifungals
    • Cell dissociation reagent
    • Buffer & Chemical
    • balanced salt solution
    • Contamination detection kit
    • Adhesin and matrix factor
    • Other cell culture reagents

(Other cell culture reagents include chelators, antioxidants, sugars, vitamins, stains and pigments)

Cell Culture Reagent Market by Application

  • biological production
    • monoclonal antibody production
    • Production of therapeutic proteins
    • vaccine production
    • Cell/gene therapy
  • diagnose
  • cancer research
  • Drug screening and development
  • stem cell research

Cell Culture Reagent Market by End User

  • Pharmaceutical and biotech companies
  • Academic/research institution
  • diagnostic laboratory

Cell culture reagent market by region

  • North America
  • Europe
    • Germany
    • France
    • England
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • latin america
  • Middle East and Africa

Download a free sample report now @

Related reports:

Biopharmaceutical Processing Equipment and Consumables Market by Product Type {Filtration, Chromatography [Consumables, Equipment]Disposable Bioreactors, Cell Culture Media, Shakers, Services), Applications (Vaccines, mAbs, R&D), and End Users – Forecast to 2029

In Vitro Toxicology/Toxicology Testing Market by Products and Services, Technologies (Cell Culture, OMICS), Methods (Cell-Based Assays, In Silico), Endpoints (ADME, Genotoxicity, Organ Toxicity, Skin Toxicity), End-Users, Geography – Global Forecast to 2025

Cell Separation/Cell Separation Market by Product (Reagents, Beads, Media, Disposables, Centrifuges, Filtration Systems), Cell Type (Human, Animal), Technology (Filtration, Surface Markers), Application (Research, Therapeutics) ), End Users – Global Forecast to 2024

About Meticulus Research®

Meticulous Research® was established in 2010 and incorporated in 2013 as a private limited liability company under the Meticulous Market Research Pvt. Companies Act, 1956. Since its inception, the company has become a leading provider of premium market information in North America, Europe, Asia Pacific, Latin America, Middle East and Africa. .

Our name defines our services, strengths and values. Since our inception, we have only succeeded in researching, analyzing and presenting important market data with meticulous attention to detail. With rigorous primary and secondary research techniques, we build powerful capabilities in data collection, interpretation and analysis, including qualitative and quantitative research by our team of top analysts. We design meticulously analyzed, intelligent, value-driven syndicated market research reports, custom research, rapid turnaround research and consulting solutions to address the business challenges of sustainable growth.

Mr. Kushal Bombe
Meticulus Market Research Inc.
1267 Willis Street, Ste 200 Reading,
California, 96001, USA
United States: +1-646-781-8004
Europe : +44-203-868-8738
Asia Pacific: +91 744-7780008
Visit our website:
Connect with us on LinkedIn-
Content source: